SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

NBIS is experiencing a significant pullback, leading to community discussions about potential bottom levels and whether it's a buying opportunity or a sign of deeper issues. Despite the recent downturn, some investors maintain a bullish outlook, citing the Microsoft deal and long-term growth potential in the AI sector, while others express concerns about overvaluation and potential further declines.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending as earnings approach, with community chatter focused on potential subscriber growth and the impact of new content. Some traders are speculating on a possible stock split announcement, while others debate the company's valuation and future performance. The stock's resilience amidst broader market volatility is also being noted.

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease. The company was founded by Rogerio Vivaldi Coelho and Goeffrey Robin Race on April 23, 2007 and is headquartered in Burlington, MA.

Minerva Neurosciences Inc

Minerva Neurosciences ($NERV) is trending after announcing a $200M financing deal, sparking a surge in price and high volatility. The community is debating the potential for a short squeeze versus dilution concerns, while some traders are shifting focus to other trending stocks like $BYND. Bullish investors are optimistic about the Phase 3 trial for their schizophrenia treatment.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

WBD is trending due to speculation around a potential acquisition, with community members weighing the possibility of a deal with Paramount Skydance or other interested parties like Netflix and Comcast. Discussions involve potential offer prices, the company's debt, and the strategic value of WBD's content library. The community is actively debating the likelihood of a buyout versus the company proceeding with its planned separation.

Sweetgreen, Inc. owns and operates a chain of salad restaurants. It offers drinks, sides, local bowls, salads, plates, and warm bowls. The company was founded by Nicolas Jammet, Jonathan Neman, and Nathaniel E. Ru in November 2006 and is headquartered in Los Angeles, CA.

Sweetgreen Inc - Ordinary Shares - Class A

Sweetgreen ($SG) is trending as investors discuss its potential as a robotics play, especially compared to its peers; the acquisition of SPYCE is getting attention. Some traders are weighing whether to accumulate shares long-term, citing the company's cheap valuation compared to competitors, while others point to upcoming earnings as a possible catalyst. Recent commentary from Wells Fargo adjusting its rating to Overweight has also entered the conversation.

rYojbaba Co., Ltd. engages in providing consulting and health services to improve and restore physical and mental health diminished by work-related stress. It operates through the Labor Consulting Services and Health Services segments. The Labor Consulting Services segment provides labor and corporate consulting services to foster constructive employment relationships between companies and employees. The Health Services segment provides health services through osteopathic clinics and osteopathic beauty salons to alleviate physical ailments primarily created by work related stress. The company was founded by Masataka Sakai on January 5, 2015 and is headquartered in Fukuoka, Japan.

rYojbaba Co. Ltd.

rYojbaba Co., Ltd. 

rYojbaba Co., Ltd. ($RYOJ) is trending due to a significant surge in price and volume, prompting discussions about potential short squeezes and comparisons to other recent high-momentum stocks. The community is actively speculating on targets and potential sympathy plays, with some noting the stock's low float and recent IPO status. News of partnerships may be contributing to market stimulation.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is trending due to a volatile reaction to earnings and a strategic pivot towards rare earth mineral production. Community members are debating the viability of the rare earth venture and the impact of a Wells Fargo downgrade, while also speculating about potential acquisitions. Overall, the discussion revolves around whether this rally is a sign of a true transformation or just another fleeting moment.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets and Data Centers. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

Galaxy Digital ($GLXY) is trending as investors anticipate earnings results, with community chatter focused on AI data center revenue potential and the company's strategic positioning in crypto finance. Discussions highlight Galaxy's potential to outperform peers, driven by strong earnings and the upcoming Helios data center, though some express concern over range-bound price action and short selling. The community is closely watching for a breakout and analyst upgrades following the earnings release.

Terra Innovatum Global NV operates as a holding company that offers micro-reactor solutions. It engages in the development of nuclear micro modular solutions focused on clean energy. The firm's nuclear technology, the SOLO features a thermally-moderated, gas-cooled nuclear reactor core that operates with standard enrichment U235 and conventional Zircaloy-cladded UO2 fuel pellets. The company was founded on April 29, 2025 and is headquartered in Lucca, Italy.

Terra Innovatum Global N.V.

Terra Innovatum Global N.V. Ordinary shares

NKLR is trending downwards as investors discuss the stock's post-merger performance and compare it to sector peers like OKLO. Community sentiment suggests concerns about the company's plans and potential for a reverse split, while some traders are speculating about short-term manipulation and potential for a future rebound based on the nuclear sector's long-term prospects.

GSI Technology, Inc. engages in the design, development and marketing of memory products primarily for the networking, and telecommunications markets. Its product includes Static Random Access Memory, or SRAM, which incorporated in networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations and network access equipment. It also offers services to the ongoing needs of the military, industrial, test and measurement equipment, automotive and medical markets for SRAMs .The company was founded by Lee-Lean Shu and Robert Yau in March 1995 and is headquartered in Sunnyvale, CA.

GSI Technology Inc

GSIT is trending due to excitement around its Gemini APU, which a Cornell study showed matches GPU performance with significantly less energy consumption. The community is discussing potential partnerships, buyout scenarios, and the long-term implications for AI and data centers, while some are wary of a recent stock offering impacting the price. Overall, the focus is on GSIT's potential to disrupt the AI market with its energy-efficient technology.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

An Overview of Adaptimmune Therapeutics's Earnings

Adaptimmune Enhances Severance Benefits for Executives

Adaptimmune Therapeutics (ADAP) has issued an update. Adaptimmune Therapeutics plc updated their executive severance policy, enhancing the benefits...

Adaptimmune Therapeutics (NASDAQ:ADAP) shareholders are up 18% this past week, but still in the red over the last three years

It is a pleasure to report that the Adaptimmune Therapeutics plc ( NASDAQ:ADAP ) is up 99% in the last quarter. But...

Results of Adaptimmune's SPEARHEAD-1 Trial with Afami-cel in Advanced Sarcomas Published in the Lancet

Philadelphia, Pennsylvania and Oxford, United Kindgom--(Newsfile Corp. - March 27, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company redefining the treatment of solid tumor cancers with...

Adaptimmune Therapeutics (NASDAQ:ADAP) Trading Down 2.1%

Adaptimmune Therapeutics plc (NASDAQ:ADAP  Get Free Report) fell 2.1% on Tuesday . The company traded as low as $1.41 and last traded at $1.41. 62,343 shares were traded during trading, a...

Analysts Offer Insights on Healthcare Companies: Adaptimmune Therapeutics (ADAP), Elevation Oncology (ELEV) and AC Immune SA (ACIU)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Adaptimmune Therapeutics (ADAP Research Report), Elevation Oncology...

Adaptimmune Therapeutics PLC Reports Q4 and Full Year 2023 Financial Results

Key Financial Highlights and Business UpdatesRelated Stocks: ADAP...

Buy Rating Affirmed for Adaptimmune on Upcoming Milestones and Promising Trial Results

Adaptimmune Therapeutics (ADAP Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Soumit Roy...

Adaptimmune Reports Q4/Full Year 2023 Financial Results and Business Updates

U.S. FDA accepted BLA for afami-cel for the treatment of advanced synovial sarcoma with priority review and a PDUFA date of August 4th, 2024Confirmatory evidence for afami-cel full approval agreed...

Adaptimmune Therapeutics plc (NASDAQ:ADAP) Sees Large Decrease in Short Interest

Adaptimmune Therapeutics plc (NASDAQ:ADAP  Get Free Report) was the recipient of a large decrease in short interest in the month of February. As of February 15th, there was short interest...

Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.

Adaptimmune Therapeutics Plc - ADR

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$0.05	--	--	N/A
Q2 '25	-$0.04	-$0.02	48.72%	BEAT
Q1 '25	-$0.09	-$0.03	64.81%	BEAT
Q4 '24	-$0.04	--	--	N/A
Q3 '24	-$0.01	-$0.01	-5.74%	MISSED

ADAP
Adaptimmune Therapeutics

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest ADAP News

ADAPAdaptimmune Therapeutics